Stentys SA

Type: Company
Name: Stentys SA
Nationality: United States
Fact Sheet: Fact Sheet for Stentys
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Novel Self-Apposing Stents To Treat Coronary Heart Disease

A French medtech company has developed the first self-apposing stent to treat acute myocardial infarction. It might represent the start of a new era in the treatment of coronary heart disease. This global market is worth an estimated 2 billion dollar ... [Published European Medical Device Technology - 21 hours ago]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

BRIEF-Stentys creates branch office in Dubai

Sept 25 (Reuters) - Stentys SA :* Announces creation of a branch office in DubaiSource text for Eikon:Further company coverage:(Gdynia Newsroom: +48 58 698 39 2 ... [Published Reuters UK - Sep 25 2014]
Entities: Dubai, Stentys SA
First reported Sep 22 2014 - Updated Sep 23 2014 - 1 reports

BRIEF-Stentys reports H1 net loss of 13.19 mln euros vs loss of 5.69 mln euros last year

Sept 22 (Reuters) - Stentys SA :* Says H1 net loss is 13.19 million euros versus loss of5.69 million euros last year* Says H1 revenue is 1.93 million euros versus 1.63 millioneuros last year* Says to had cash of 23.1 million euros at June 30Source text ... [Published Reuters UK - Sep 22 2014]
Entities: Stentys SA
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

STENTYS Reports First Half 2014 Financial Results -2-

This press release contains forward-looking statements about the Company's business. Such forward looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which it will ... [Published Scottrade - Sep 22 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 2 reports

Stentys announces positive results of Apposition III study

Stentys SA:Announces positive results of 1,000 patient Apposition III clinical study at two years after treatment of severe heart attack.At two years, MACE (defined as the composite of cardiac death, target-vessel myocardial infarction, emergent by-pass ... [Published Reuters UK - Sep 19 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 5 reports

STENTYS Stent Continues to Show Low Mortality Two Years after Treatment of a Heart Attack

Regulatory News :Click to Continue » ... [Published Fort Mills Times - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

BRIEF-Stentys announces positive results of Apposition III study

Sept 16 (Reuters) - Stentys SA :* Announces positive results of 1,000 patient Apposition IIIclinical study at two years after treatment of severe heartattack* At two years, MACE (defined as the composite of cardiacdeath, target-vessel myocardial infarction, ... [Published Reuters UK - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 2 reports

STENTYS Stent Continues to Show Low Mortality Two Years after Treatment of a Heart Attack

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), ... [Published Business Wire Science: Science News - Sep 16 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 2 reports

Stentys Hits Milestone of 10K Self-Apposing Stent Implantations

Stentys reported that the Self-Apposing stent has been implanted over 10,000 times in patients worldwide. According to a company release, this milestone further illustrates the popularity of Stentys' technology among cardiologists in Europe and a growing ... [Published Individual.com - Sep 08 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 3 reports

STENTYS Reaches 10,000 Self-Apposing Stent implantations

PRINCETON, N.J. & PARIS--(EON: Enhanced Online News)--STENTYS Reaches 10,000 Self-Apposing Stent implantations. ... [Published EON Science - Sep 03 2014]
Entities: Stentys SA, Stent, Paris
First reported Aug 25 2014 - Updated Aug 26 2014 - 1 reports

STENTYS to Report First-Half Results on September 22, 2014

--Regulatory News:STENTYS (Paris:STNT) (FR0010949404 -- STNT), a medical technology company commercializing, in Europe, the world's first and only Self-Apposing(R) stent to treat acute myocardial infarction (AMI), today announces it will report financial ... [Published Scottrade - Aug 25 2014]
First reported Apr 29 2014 - Updated Apr 29 2014 - 3 reports

STENTYS’ Self-Apposing Stent Featured in New Article Published by the Journal of the American College of Cardiology

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS' Self-Apposing Stent has been highlighted as a solution to minimize stent malapposition in a new article published by the Journal of the American College of Cardiology. ... [Published Business Wire Science: Science News - Apr 29 2014]

Quotes

Gonzague Issenmann , Chief Executive Officer and co-founder of Stentys , stated: "The continued strength of the clinical data for the Self-Apposing platform in the very long run is yet another body of evidence supporting the superiority of our technology in the treatment of AMI."
"The 10,000th stent implanted represents a major milestone in the company's history," said Gonzague Issenmann, CEO and co-founder of Stentys. "We look forward to educating an even greater number of cardiologists and continuing our expansion to the benefit of all the patients worldwide that cannot be optimally treated with conventional balloon expandable stents."
He also agrees that "patients with high thrombus burden may benefit more from thrombectomy, but further data are needed. Less than a third of patients had"
and other countries, Dr Elliott Antman (Harvard Medical School, Boston, MA) observed: "That would require allowing our"

More Content

All (38) | News (18) | Reports (0) | Blogs (19) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Novel Self-Apposing Stents To Treat Coronary He... [Published European Medical Device Technology - 21 hours ago]
BRIEF-Stentys creates branch office in Dubai [Published Reuters UK - Sep 25 2014]
BRIEF-Stentys reports H1 net loss of 13.19 mln ... [Published Reuters UK - Sep 22 2014]
STENTYS Reports First Half 2014 Financial Resul... [Published Scottrade - Sep 22 2014]
Stentys announces positive results of Appositio... [Published Reuters UK - Sep 19 2014]
Stentys : Stent Updates on Apposition III [Published 4 Traders - Sep 19 2014]
BRIEF-Stentys announces positive results of App... [Published Reuters UK - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published Fort Mills Times - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published Digital Journal - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published Nasdaq - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published Scottrade - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published EON Science - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published Business Wire Science: Science News - Sep 16 2014]
STENTYS Stent Continues to Show Low Mortality T... [Published Business Wire Health News - Sep 16 2014]
Global Bifurcation Leader Tryton Medical Announ... [Published SearchBug - Sep 12 2014]
Stentys Hits Milestone of 10K Self-Apposing Ste... [Published Individual.com - Sep 08 2014]
Stentys Reports Milestone for Self-Apposing Ste... [Published Individual.com - Sep 08 2014]
TASTE at One Year: No Gains from Thrombectomy i... [Published General Medicine eJournal - Sep 03 2014]
STENTYS Reaches 10,000 Self-Apposing Stent impl... [Published EON Science - Sep 03 2014]
STENTYS Reaches 10,000 Self-Apposing Stent impl... [Published Business Wire Science: Science News - Sep 03 2014]
STENTYS Reaches 10,000 Self-Apposing Stent impl... [Published Business Wire Health News - Sep 03 2014]
Brilinta Prehospital: No Reperfusion Boost, Les... [Published American Journal of Public Health - Sep 02 2014]
Prehospital Ticagrelor in ST-Segment Elevation ... [Published New England Journal of Medicine - Sep 01 2014]
STENTYS to Report First-Half Results on Septemb... [Published Scottrade - Aug 25 2014]
STENTYS First Half 2014 Revenues Rise 18% [Published Business Wire Health News - Jul 24 2014]
STENTYS Expands Marketing of the Self-Apposing ... [Published Business Wire Health News - Jul 09 2014]
STENTYS Completes the Acquisition of Cappella P... [Published Business Wire Health News - Jun 12 2014]
STENTYS to Acquire Stent Delivery Technology fo... [Published Business Wire Health News - Jun 04 2014]
STENTYS Self-Apposing Stent Featured Prominentl... [Published Business Wire Health News - May 27 2014]
STENTYS Sirolimus-Eluting Stent Demonstrates Be... [Published Business Wire Health News - May 20 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
STENTYS Stent Continues to Show Low Mortality T... [Published EON Science - Sep 16 2014]
PRINCETON, N.J. & PARIS--(EON: Enhanced Online News)--Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction ...
STENTYS Stent Continues to Show Low Mortality T... [Published Business Wire Science: Science News - Sep 16 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), ...
STENTYS Stent Continues to Show Low Mortality T... [Published Business Wire Health News - Sep 16 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), ...
STENTYS Reaches 10,000 Self-Apposing Stent impl... [Published EON Science - Sep 03 2014]
PRINCETON, N.J. & PARIS--(EON: Enhanced Online News)--STENTYS Reaches 10,000 Self-Apposing Stent implantations. ...
STENTYS Reaches 10,000 Self-Apposing Stent impl... [Published Business Wire Science: Science News - Sep 03 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS Reaches 10,000 Self-Apposing Stent implantations. ...
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.